Skip to content Skip to footer

International Cannabis Weekly: 244

April 22, 2022

Highlights

Share this story
Share on twitter
Share on linkedin
Share on email

THE GERMAN GOVERNMENT HAS ‘SET THE BAR SO HIGH’ FOR ADULT-USE CANNABIS MARKET

Since Germany’s ‘traffic light coalition’ was voted in late last year, bringing with it the promise of a recreational cannabis market in Europe’s largest economy, a new wave of investment has flooded into the sector.

While the excitement surrounding the opportunity is justified, a number of significant hurdles remain for the German government to overcome before the nascent market can reach its full potential.

Ahead of Cannabis Europa London 2022, BusinessCann spoke to Carlsquare’s Arnold Holle to discuss the challenges and opportunities, and whether the Government may have bitten off more than it can chew.

READ MORE »

FIRST HARVEST OF GERMAN-GROWN MEDICAL CANNABIS AVAILABLE TO PHARMACIES

READ MORE »

THE FIRST LEGAL ADULT-USE CANNABIS SALES BEGIN IN NEW JERSEY

READ MORE »

Highlights

Share this story
Share on twitter
Share on linkedin
Share on email
Europe
  • UK CBD industry steps closer to full compliance with regulations, however question marks remain over THC limits.
  • Sardinian officials say that a new law which regulates farming and processing will speed up the hemp supply chain.
  • Cantourage has received a licence that will allow them to supply products to UK medical cannabis patients.
  • Akanda is set to acquire Portugal-based Holigen and be granted EU-GMP market access.
  • Little Green Pharma signs a sales agreement for the supply of medical cannabis flower into Germany.
  • Can4Med has obtained Polish authorisation to supply medical cannabis products to pharmacies.
  • Hemp Synergistics has collaborated with Rinus Beintema to deliver hemp-infused treatments for thousands of patients.
  • CHILL Brands has announced a major reshuffle of its c-suite, including instating a 26-year-old CEO.

Highlights

Share this story
Share on twitter
Share on linkedin
Share on email
United States

Highlights

Share this story
Share on twitter
Share on linkedin
Share on email
Live Webinar

JOIN US FOR AN EXCLUSIVE EUROPEAN CANNABIS INDUSTRY WEBINAR

Join panellists from Prohibition Partners, and industry experts from sponsors of The European Cannabis Report: 7th Edition, including Cansativa Group, Fluence and Cantourage, as we discuss the trends driving the European cannabis industry forward, business opportunities, legislative momentum – and more.

Register to watch it live for free on Wednesday 27 April at 15:00 BST / 16:00 CET / 10:00 EST.

REGISTER NOW »

Highlights

Share this story
Share on twitter
Share on linkedin
Share on email
Canada

Highlights

Share this story
Share on twitter
Share on linkedin
Share on email
LATAM & The Caribbean

Highlights

Share this story
Share on twitter
Share on linkedin
Share on email
Upcoming Event

 

A LIMITED NUMBER OF ADVANCED TICKETS REMAIN – SAVE UP TO £100

Join us on 28 – 29 June for the most ambitious Cannabis Europa event to date, at the iconic Old Billingsgate venue on the bank of the River Thames. With a tidal wave of legislative momentum hitting Europe, there has never been a more crucial time to navigate the European market as it enters its most important phase.

Secure your Advanced Tickets for Cannabis Europa London and save up to £100 – sales end at midnight on Thursday 28 April. 

SECURE YOUR SEAT »

Highlights

Share this story
Share on twitter
Share on linkedin
Share on email
APAC
  • Zelira Therapeutics has announced its execution of a binding scheme to acquire Health House.
  • India’s first hemp cafe wants to open up conversations on cannabis and break the stigma around the plant.
  • New Zealand’s first licence renewal and expansion will enable Helius to produce home-grown products.
  • Cannabis advocates push for decriminalisation and removal from anti-drug campaigns in Taiwan.
  • Figures from Australia’s TGA indicate the agency is busy with SAS Category B approvals for medicinal cannabis.
  • After launching its first medical cannabis product, Rua Bioscience says there are more in the pipeline.

Highlights

Share this story
Share on twitter
Share on linkedin
Share on email
Africa & The Middle East
  • Zimbabwe Tobacco Board tells 145,000 farmers that a quarter of their income must come from hemp by 2025.
  • MedTEC Pharma has signed a A$10 million product supply contract with a major pharma company.
  • Yaakov Shachar establishes a new cannabis company with well-known medical cannabis patients named Plantis.
  • Former DA MP says she supports the proposed amendments to the Cannabis for Private Purposes bill.
Latest Issues

248

247

246

245

244

243

Insights

On the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 70,000+ subscribers.